The barrier to entry is extremely high. There are regulatory hurdles, hurdles to being taken seriously, etc. You need authorization for human trials, you need to get published, you need to convince insurance companies to pay for your product.
The same as for the first drug manufacturer, I suppose. And if you really have a superior product, you should be able to take all the customers, assuming that the customers are smart enough.
